OPOCX Mutual Fund

OPOCX Mutual Fund

NAV$115.73
See how much of OPOCX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Aug 31, 2026

Net Assets
-
Expense Ratio
1.03%
Dividend Yield (Current)
11.15%
Holdings
101
Inception Date
Sep 11, 1986
Fund Family
Invesco (US)
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+20.30%
1 Year+30.89%
3 Year+21.27%
5 Year+7.06%
10 Year+16.70%

Asset Allocation

Stocks: 96.28%
Cash: 1.38%
Other: 2.34%
See how much of OPOCX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
LGNDLigand Pharmaceuticals, Inc.2.43%
BTSGBrightspring Health2.34%
FROGJfrog Ltd2.30%
GHGuardant Health, Inc2.09%
RGENRepligen Corp2.00%
Top 10 Concentration: 20.44%Report Date: Aug 31, 2026
Download all 101 holdings for OPOCX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
11.15%
Frequency
Annually
Latest Distribution
$21.35
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

OPOCX Mutual Fund Overview

OPOCX Mutual Fund (Invesco Discovery Fund Class A) is managed by Invesco (US). OPOCX expense ratio is 1.03%, holding 101 positions across sectors including Health Care, Information Technology, Industrials. Inception date: 1986-09-11.

OPOCX performance shows a YTD return of 20.30%. The 1-year return is 30.89% and the 5-year return is 7.06%. OPOCX dividend yield stands at 11.15%, paid annually.

OPOCX top holdings include Ligand Pharmaceuticals, Inc. (2.4%), Brightspring Health (2.3%), Jfrog Ltd (2.3%), Guardant Health, Inc (2.1%), Repligen Corp (2.0%). Go to all OPOCX holdings, OPOCX sectors, or OPOCX dividends.

OPOCX can be compared against other funds. Use OPOCX overlap to find shared positions, or OPOCX vs another fund for a side-by-side view. OPOCX alternatives are available via the screener, along with tax-loss harvesting opportunities.